Olmesartan medoxomil 5 MG Oral Tablet — RxCUI 349373
RxNorm drug concept · Semantic clinical drug
RxCUI 349373
Semantic clinical drug · SCD
● Current RxNorm concept 83 FDA products
239 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI349373
Official nameOlmesartan medoxomil 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped83
Package NDCs mapped239
Reported Medicaid activity (SDUD)339,880 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Olmesartan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Olmesartan is used to treat high blood pressure (hypertension) in adults and in kids as young as six years old. It works by relaxing your blood vessels so your heart doesn't have t...
- No — this is one of the most important things to know about olmesartan. It can cause very serious harm to an unborn baby, including kidney failure and even death, especially after...
- Can I take this if I'm pregnant or trying to get pregnant?
- Dizziness is the most commonly reported side effect — it happens in about 3 out of 100 people in clinical trials. It's most likely when you first start the medicine, especially if...
🕸️ Concept Web — How Olmesartan medoxomil 5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Olmesartan medoxomil 5 MG Oral Tablet
RxCUI 349373 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Olmesartan
321064IN -
Olmesartan medoxomil
118463PIN
-
Olmesartan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Benicar
327503BN
-
Benicar
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Olmesartan Oral Tablet
378991SCDF -
Olmesartan medoxomil Oral Tablet
2646044SCDFP -
Olmesartan Oral Product
1159559SCDG -
Olmesartan Pill
1159560SCDG -
Olmesartan medoxomil Oral Product
2663366SCDGP -
Olmesartan medoxomil Pill
2660825SCDGP -
Olmesartan Oral Tablet [Benicar]
369419SBDF -
Olmesartan medoxomil Oral Tablet [Benicar]
2655442SBDFP - +5 more in this family
-
Olmesartan Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Olmesartan medoxomil 5 MG
359115SCDC -
Olmesartan medoxomil 5 MG Oral Tablet [Benicar]
352199SBD -
Olmesartan medoxomil 5 MG [Benicar]
575926SBDC
-
Olmesartan medoxomil 5 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Olmesartan medoxomil 5 MG
SCDC · 359115 -
Olmesartan Oral Tablet
SCDF · 378991 -
Olmesartan medoxomil Oral Tablet
SCDFP · 2646044 -
Olmesartan Oral Product
SCDG · 1159559 -
Olmesartan Pill
SCDG · 1159560 -
Olmesartan medoxomil Oral Product
SCDGP · 2663366 -
Olmesartan medoxomil Pill
SCDGP · 2660825
Brand-Name Concepts
-
Olmesartan medoxomil 5 MG Oral Tablet [Benicar]
SBD · 352199 -
Olmesartan medoxomil 5 MG [Benicar]
SBDC · 575926 -
Olmesartan Oral Tablet [Benicar]
SBDF · 369419 -
Olmesartan medoxomil Oral Tablet [Benicar]
SBDFP · 2655442 -
Benicar Oral Product
SBDG · 1170823 -
Benicar Pill
SBDG · 1171463 -
Benicar
BN · 327503
📦 FDA Products & Package NDCs
83 products · 239 package NDCs
239 package NDCs map to RxCUI 349373 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00527-2425-32 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-2425-32) | OLMESARTAN MEDOXOMIL | Lannett Company, Inc. | 2019-03-05 |
| 00527-2425-46 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-2425-46) | OLMESARTAN MEDOXOMIL | Lannett Company, Inc. | 2019-03-05 |
| 00527-2426-32 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-2426-32) | OLMESARTAN MEDOXOMIL | Lannett Company, Inc. | 2019-03-05 |
| 00527-2426-46 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-2426-46) | OLMESARTAN MEDOXOMIL | Lannett Company, Inc. | 2019-03-05 |
| 00527-2427-32 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-2427-32) | OLMESARTAN MEDOXOMIL | Lannett Company, Inc. | 2019-03-05 |
| 00527-2427-46 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-2427-46) | OLMESARTAN MEDOXOMIL | Lannett Company, Inc. | 2019-03-05 |
| 00713-0860-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0860-30) | Benicar | Cosette Pharmaceuticals, Inc. | 2022-09-01 |
| 00713-0861-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0861-30) | Benicar | Cosette Pharmaceuticals, Inc. | 2022-09-01 |
| 00713-0862-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0862-30) | Benicar | Cosette Pharmaceuticals, Inc. | 2022-09-01 |
| 00713-0940-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0940-30) | Benicar | Cosette Pharmaceuticals, Inc. | 2025-10-01 |
| 00713-0941-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0941-30) | Benicar | Cosette Pharmaceuticals, Inc. | 2025-08-01 |
| 00713-0942-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0942-30) | Benicar | Cosette Pharmaceuticals, Inc. | 2025-12-01 |
| 16729-0320-10 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-320-10) | olmesartan medoxomil | Accord Healthcare Inc. | 2018-02-16 |
| 16729-0320-15 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-320-15) | olmesartan medoxomil | Accord Healthcare Inc. | 2018-02-16 |
| 16729-0321-10 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-321-10) | olmesartan medoxomil | Accord Healthcare Inc. | 2017-04-27 |
| 16729-0321-15 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-321-15) | olmesartan medoxomil | Accord Healthcare Inc. | 2017-04-27 |
| 16729-0321-17 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-321-17) | olmesartan medoxomil | Accord Healthcare Inc. | 2017-04-27 |
| 16729-0322-10 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-322-10) | olmesartan medoxomil | Accord Healthcare Inc. | 2017-04-27 |
| 16729-0322-15 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-322-15) | olmesartan medoxomil | Accord Healthcare Inc. | 2017-04-27 |
| 16729-0322-17 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16729-322-17) | olmesartan medoxomil | Accord Healthcare Inc. | 2017-04-27 |
| 31722-0852-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-852-30) | OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 2025-05-23 |
| 31722-0852-90 | 90 TABLET, FILM COATED in 1 BOTTLE (31722-852-90) | OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 2025-05-23 |
| 31722-0853-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-853-30) | OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 2025-05-23 |
| 31722-0853-90 | 90 TABLET, FILM COATED in 1 BOTTLE (31722-853-90) | OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 2025-05-23 |
| 31722-0854-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-854-30) | OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 2025-05-23 |
| 31722-0854-90 | 90 TABLET, FILM COATED in 1 BOTTLE (31722-854-90) | OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 2025-05-23 |
| 33342-0178-07 | 30 TABLET in 1 BOTTLE (33342-178-07) | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0178-10 | 90 TABLET in 1 BOTTLE (33342-178-10) | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0178-12 | 10 BLISTER PACK in 1 CARTON (33342-178-12) / 10 TABLET in 1... | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0178-44 | 1000 TABLET in 1 BOTTLE (33342-178-44) | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0179-07 | 30 TABLET in 1 BOTTLE (33342-179-07) | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0179-10 | 90 TABLET in 1 BOTTLE (33342-179-10) | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0179-12 | 10 BLISTER PACK in 1 CARTON (33342-179-12) / 10 TABLET in 1... | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0179-44 | 1000 TABLET in 1 BOTTLE (33342-179-44) | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0180-07 | 30 TABLET in 1 BOTTLE (33342-180-07) | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0180-10 | 90 TABLET in 1 BOTTLE (33342-180-10) | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0180-12 | 10 BLISTER PACK in 1 CARTON (33342-180-12) / 10 TABLET in 1... | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 33342-0180-44 | 1000 TABLET in 1 BOTTLE (33342-180-44) | Olmesartan medoxomil | Macleods Pharmaceuticals Limited | 2017-04-25 |
| 42571-0201-05 | 500 TABLET, FILM COATED in 1 BOTTLE (42571-201-05) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0201-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42571-201-10) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0201-11 | 10 BLISTER PACK in 1 CARTON (42571-201-11) / 10 TABLET, FIL... | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0201-30 | 30 TABLET, FILM COATED in 1 BOTTLE (42571-201-30) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0201-90 | 90 TABLET, FILM COATED in 1 BOTTLE (42571-201-90) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0202-05 | 500 TABLET, FILM COATED in 1 BOTTLE (42571-202-05) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0202-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42571-202-10) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0202-11 | 10 BLISTER PACK in 1 CARTON (42571-202-11) / 10 TABLET, FIL... | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0202-30 | 30 TABLET, FILM COATED in 1 BOTTLE (42571-202-30) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0202-90 | 90 TABLET, FILM COATED in 1 BOTTLE (42571-202-90) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0203-05 | 500 TABLET, FILM COATED in 1 BOTTLE (42571-203-05) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
| 42571-0203-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42571-203-10) | OLMESARTAN MEDOXOMIL | Micro Labs Limited | 2020-02-03 |
Observed labelers:
Ascend Laboratories, LLC (16) ·
Aurobindo Pharma Limited (16) ·
Micro Labs Limited (15) ·
Jubilant Cadista Pharmacuticals Inc. (14) ·
Alembic Pharmaceuticals Inc. (12) ·
Alembic Pharmaceuticals Limited (12)
· +21 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.